156 related articles for article (PubMed ID: 36874403)
1. Stromal FAP Expression is Associated with MRI Visibility and Patient Survival in Prostate Cancer.
Pellinen T; Sandeman K; Blom S; Turkki R; Hemmes A; Välimäki K; Eineluoto J; Kenttämies A; Nordling S; Kallioniemi O; Rannikko A; Mirtti T
Cancer Res Commun; 2022 Mar; 2(3):172-181. PubMed ID: 36874403
[TBL] [Abstract][Full Text] [Related]
2. Associations of PTEN and ERG with Magnetic Resonance Imaging Visibility and Assessment of Non-organ-confined Pathology and Biochemical Recurrence After Radical Prostatectomy.
Eineluoto JT; Sandeman K; Pohjonen J; Sopyllo K; Nordling S; Stürenberg C; Malén A; Kilpeläinen TP; Santti H; Petas A; Matikainen M; Pellinen T; Järvinen P; Kenttämies A; Rannikko A; Mirtti T
Eur Urol Focus; 2021 Nov; 7(6):1316-1323. PubMed ID: 32620540
[TBL] [Abstract][Full Text] [Related]
3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
4. Histomic and transcriptomic features of MRI-visible and invisible clinically significant prostate cancers are associated with prognosis.
Lehto TK; Pylväläinen J; Sandeman K; Kenttämies A; Nordling S; Mills IG; Tang J; Mirtti T; Rannikko A
Int J Cancer; 2024 Mar; 154(5):926-939. PubMed ID: 37767987
[TBL] [Abstract][Full Text] [Related]
5. Immune cell analyses of the tumor microenvironment in prostate cancer highlight infiltrating regulatory T cells and macrophages as adverse prognostic factors.
Andersen LB; Nørgaard M; Rasmussen M; Fredsøe J; Borre M; Ulhøi BP; Sørensen KD
J Pathol; 2021 Oct; 255(2):155-165. PubMed ID: 34255349
[TBL] [Abstract][Full Text] [Related]
6. Stromal FAP is an independent poor prognosis marker in non-small cell lung adenocarcinoma and associated with p53 mutation.
Moreno-Ruiz P; Corvigno S; Te Grootenhuis NC; La Fleur L; Backman M; Strell C; Mezheyeuski A; Hoelzlwimmer G; Klein C; Botling J; Micke P; Östman A
Lung Cancer; 2021 May; 155():10-19. PubMed ID: 33706022
[TBL] [Abstract][Full Text] [Related]
7. Single-cell Spatial Proteomic Revelations on the Multiparametric MRI Heterogeneity of Clinically Significant Prostate Cancer.
Pachynski RK; Kim EH; Miheecheva N; Kotlov N; Ramachandran A; Postovalova E; Galkin I; Svekolkin V; Lyu Y; Zou Q; Cao D; Gaut J; Ippolito JE; Bagaev A; Bruttan M; Gancharova O; Nomie K; Tsiper M; Andriole GL; Ataullakhanov R; Hsieh JJ
Clin Cancer Res; 2021 Jun; 27(12):3478-3490. PubMed ID: 33771855
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy.
Gandaglia G; Ploussard G; Valerio M; Marra G; Moschini M; Martini A; Roumiguié M; Fossati N; Stabile A; Beauval JB; Malavaud B; Scuderi S; Barletta F; Afferi L; Rakauskas A; Gontero P; Mattei A; Montorsi F; Briganti A
Eur Urol Oncol; 2020 Dec; 3(6):739-747. PubMed ID: 32847747
[TBL] [Abstract][Full Text] [Related]
9. A Magnetic Resonance Imaging-Based Prediction Model for Prostate Biopsy Risk Stratification.
Mehralivand S; Shih JH; Rais-Bahrami S; Oto A; Bednarova S; Nix JW; Thomas JV; Gordetsky JB; Gaur S; Harmon SA; Siddiqui MM; Merino MJ; Parnes HL; Wood BJ; Pinto PA; Choyke PL; Turkbey B
JAMA Oncol; 2018 May; 4(5):678-685. PubMed ID: 29470570
[TBL] [Abstract][Full Text] [Related]
10. Tumor contact with prostate capsule on magnetic resonance imaging: A potential biomarker for staging and prognosis.
Kongnyuy M; Sidana A; George AK; Muthigi A; Iyer A; Ho R; Chelluri R; Mertan F; Frye TP; Su D; Merino MJ; Choyke PL; Wood BJ; Pinto PA; Turkbey B
Urol Oncol; 2017 Jan; 35(1):30.e1-30.e8. PubMed ID: 27567248
[TBL] [Abstract][Full Text] [Related]
11. Genes involved in prostate cancer progression determine MRI visibility.
Li P; You S; Nguyen C; Wang Y; Kim J; Sirohi D; Ziembiec A; Luthringer D; Lin SC; Daskivich T; Wu J; Freeman MR; Saouaf R; Li D; Kim HL
Theranostics; 2018; 8(7):1752-1765. PubMed ID: 29556354
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Accuracy and Prognostic Value of Serial Prostate Multiparametric Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer.
Chu CE; Cowan JE; Lonergan PE; Washington SL; Fasulo V; de la Calle CM; Shinohara K; Westphalen AC; Carroll PR
Eur Urol Oncol; 2022 Oct; 5(5):537-543. PubMed ID: 33483265
[TBL] [Abstract][Full Text] [Related]
13. Why Does Magnetic Resonance Imaging-Targeted Biopsy Miss Clinically Significant Cancer?
Williams C; Ahdoot M; Daneshvar MA; Hague C; Wilbur AR; Gomella PT; Shih J; Khondakar N; Yerram N; Mehralivand S; Gurram S; Siddiqui M; Pinsky P; Parnes H; Merino M; Wood B; Turkbey B; Pinto PA
J Urol; 2022 Jan; 207(1):95-107. PubMed ID: 34433302
[TBL] [Abstract][Full Text] [Related]
14. Pathological and 3 Tesla Volumetric Magnetic Resonance Imaging Predictors of Biochemical Recurrence after Robotic Assisted Radical Prostatectomy: Correlation with Whole Mount Histopathology.
Tan N; Shen L; Khoshnoodi P; Alcalá HE; Yu W; Hsu W; Reiter RE; Lu DY; Raman SS
J Urol; 2018 May; 199(5):1218-1223. PubMed ID: 29128577
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticles Targeted to Fibroblast Activation Protein Outperform PSMA for MRI Delineation of Primary Prostate Tumors.
Dmochowska N; Milanova V; Mukkamala R; Chow KK; Pham NTH; Srinivasarao M; Ebert LM; Stait-Gardner T; Le H; Shetty A; Nelson M; Low PS; Thierry B
Small; 2023 May; 19(21):e2204956. PubMed ID: 36840671
[TBL] [Abstract][Full Text] [Related]
16. MRI-Ultrasound Fusion Targeted Biopsy of Prostate Imaging Reporting and Data System Version 2 Category 5 Lesions Found False-Positive at Multiparametric Prostate MRI.
Sheridan AD; Nath SK; Aneja S; Syed JS; Pahade J; Mathur M; Sprenkle P; Weinreb JC; Spektor M
AJR Am J Roentgenol; 2018 May; 210(5):W218-W225. PubMed ID: 29489409
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Targeted vs Systematic Prostate Biopsy in Men Who Are Biopsy Naive: The Prospective Assessment of Image Registration in the Diagnosis of Prostate Cancer (PAIREDCAP) Study.
Elkhoury FF; Felker ER; Kwan L; Sisk AE; Delfin M; Natarajan S; Marks LS
JAMA Surg; 2019 Sep; 154(9):811-818. PubMed ID: 31188412
[TBL] [Abstract][Full Text] [Related]
18. Effects of Magnetic Resonance Imaging Targeting on Overdiagnosis and Overtreatment of Prostate Cancer.
Vickers AJ
Eur Urol; 2021 Nov; 80(5):567-572. PubMed ID: 34294510
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast activation protein expression by stromal cells and tumor-associated macrophages in human breast cancer.
Tchou J; Zhang PJ; Bi Y; Satija C; Marjumdar R; Stephen TL; Lo A; Chen H; Mies C; June CH; Conejo-Garcia J; Puré E
Hum Pathol; 2013 Nov; 44(11):2549-57. PubMed ID: 24074532
[TBL] [Abstract][Full Text] [Related]
20. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]